Technical Analysis for TPST - Tempest Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 6.32% | |
Crossed Above 20 DMA | Bullish | 6.32% | |
MACD Bullish Signal Line Cross | Bullish | 6.32% | |
Inside Day | Range Contraction | 6.32% | |
Up 3 Days in a Row | Strength | 6.32% | |
20 DMA Resistance | Bearish | 12.83% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 16 hours ago |
Rose Above Upper Bollinger Band | about 16 hours ago |
Upper Bollinger Band Resistance | about 16 hours ago |
Rose Above 50 DMA | about 16 hours ago |
50 DMA Resistance | about 16 hours ago |
Get a Trading Sidekick!
- Earnings date: 03/20/2024
Tempest Therapeutics, Inc. Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company's two novel clinical programs are TPST-1495 and TPST-1120, antagonists of EP2/EP4 and PPARa. Its TPST-1495 and TPST-1120 are advancing through Phase 1 studies designed to study agents as monotherapies and in combination with other approved agents. The company is also developing an orally-available inhibitor of TREX-1 designed to activate selectively the cGAS/STING pathway, an innate immune response pathway important for the development of anti-tumor immunity. The company is headquartered in South San Francisco, California. Tempest Therapeutics Inc. operates as a subsidiary of Inception Sciences, Inc.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Tumor
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 9.0 |
52 Week Low | 0.17 |
Average Volume | 660,989 |
200-Day Moving Average | 2.54 |
50-Day Moving Average | 3.89 |
20-Day Moving Average | 3.60 |
10-Day Moving Average | 3.48 |
Average True Range | 0.31 |
RSI (14) | 55.75 |
ADX | 12.64 |
+DI | 26.83 |
-DI | 17.17 |
Chandelier Exit (Long, 3 ATRs) | 3.26 |
Chandelier Exit (Short, 3 ATRs) | 3.95 |
Upper Bollinger Bands | 4.08 |
Lower Bollinger Band | 3.13 |
Percent B (%b) | 0.78 |
BandWidth | 26.17 |
MACD Line | -0.09 |
MACD Signal Line | -0.13 |
MACD Histogram | 0.0354 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.53 | ||||
Resistance 3 (R3) | 4.53 | 4.30 | 4.42 | ||
Resistance 2 (R2) | 4.30 | 4.14 | 4.31 | 4.38 | |
Resistance 1 (R1) | 4.09 | 4.03 | 4.20 | 4.09 | 4.35 |
Pivot Point | 3.86 | 3.86 | 3.92 | 3.87 | 3.86 |
Support 1 (S1) | 3.65 | 3.70 | 3.76 | 3.65 | 3.39 |
Support 2 (S2) | 3.42 | 3.59 | 3.43 | 3.36 | |
Support 3 (S3) | 3.21 | 3.42 | 3.32 | ||
Support 4 (S4) | 3.21 |